Does BELZUTIFAN Cause Malignant neoplasm progression? 36 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Malignant neoplasm progression have been filed in association with BELZUTIFAN (WELIREG). This represents 3.5% of all adverse event reports for BELZUTIFAN.
36
Reports of Malignant neoplasm progression with BELZUTIFAN
3.5%
of all BELZUTIFAN reports
10
Deaths
11
Hospitalizations
How Dangerous Is Malignant neoplasm progression From BELZUTIFAN?
Of the 36 reports, 10 (27.8%) resulted in death, 11 (30.6%) required hospitalization.
Is Malignant neoplasm progression Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BELZUTIFAN. However, 36 reports have been filed with the FAERS database.
What Other Side Effects Does BELZUTIFAN Cause?
Anaemia (154)
Fatigue (88)
Hypoxia (85)
Diarrhoea (42)
Death (41)
Dyspnoea (40)
Haemoglobin decreased (36)
Off label use (35)
Oxygen saturation decreased (30)
Nausea (28)
What Other Drugs Cause Malignant neoplasm progression?
PEMBROLIZUMAB (10,111)
NIVOLUMAB (9,363)
ENZALUTAMIDE (4,696)
CARBOPLATIN (4,177)
EVEROLIMUS (3,789)
PACLITAXEL (3,484)
LETROZOLE (3,445)
IPILIMUMAB (3,296)
FULVESTRANT (3,221)
LENVATINIB (2,929)
Which BELZUTIFAN Alternatives Have Lower Malignant neoplasm progression Risk?
BELZUTIFAN vs BEMPEDOIC ACID
BELZUTIFAN vs BEMPEDOIC ACID\EZETIMIBE
BELZUTIFAN vs BEMPEGALDESLEUKIN
BELZUTIFAN vs BENADRYL
BELZUTIFAN vs BENAZEPRIL